ASH Joins Amicus Brief to Supreme Court About Protecting Access to FDA-Approved Drugs for Patients
Nov 14
2023
American Society of Hematology. (2023).
ASH Joins Amicus Brief to Supreme Court About Protecting Access to FDA-Approved Drugs for Patients.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joins-amicus-brief-to-supreme-court-about-protecting-access-to-fda-approved-drugs-for-patients.
American Society of Hematology.
"ASH Joins Amicus Brief to Supreme Court About Protecting Access to FDA-Approved Drugs for Patients." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joins-amicus-brief-to-supreme-court-about-protecting-access-to-fda-approved-drugs-for-patients
(label-accessed November 28, 2023).
"American Society of Hematology."
ASH Joins Amicus Brief to Supreme Court About Protecting Access to FDA-Approved Drugs for Patients, 28 Nov. 2023 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joins-amicus-brief-to-supreme-court-about-protecting-access-to-fda-approved-drugs-for-patients.
